{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:23:54Z","timestamp":1788387834285,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:00:00Z","timestamp":1724457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:00:00Z","timestamp":1724457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03314-4","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T13:02:42Z","timestamp":1724504562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The treatment of Tofacitinib for rosacea through the inhibition of the JAK\/STAT signaling pathway"],"prefix":"10.1007","volume":"316","author":[{"given":"Rui","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiping","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guomin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,24]]},"reference":[{"key":"3314_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jaad.2017.08.037","volume":"78","author":"RL Gallo","year":"2018","unstructured":"Gallo RL, Granstein RD, Kang S, Mannis M, Steinhoff M, Tan J, Thiboutot D (2018) Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol 78:148\u2013155","journal-title":"J Am Acad Dermatol"},{"key":"3314_CR2","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1056\/NEJMcp1506630","volume":"377","author":"EJ van Zuuren","year":"2017","unstructured":"van Zuuren EJ (2017) Rosacea. N Engl J Med 377:1754\u20131764","journal-title":"N Engl J Med"},{"key":"3314_CR3","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jaad.2014.08.028","volume":"72","author":"AM Two","year":"2015","unstructured":"Two AM, Wu W, Gallo RL, Hata TR (2015) Rosacea: part I. introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol 72:749\u2013758 quiz 759\u2013760","journal-title":"J Am Acad Dermatol"},{"key":"3314_CR4","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.1038\/s41388-019-0752-3","volume":"38","author":"C Recio","year":"2019","unstructured":"Recio C, Guerra B, Guerra-Rodriguez M, Aranda-Tavio H, Martin-Rodriguez P, de Mirecki-Garrido M, Brito-Casillas Y, Garcia-Castellano JM, Estevez-Braun A, Fernandez-Perez L (2019) Signal transducer and activator of transcription (STAT)-5: an opportunity for drug development in oncohematology. Oncogene 38:4657\u20134668","journal-title":"Oncogene"},{"key":"3314_CR5","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.2147\/JIR.S356551","volume":"15","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang B, Huang Y, Li Y, Yan S, Xie H, Zhang Y, Li J (2022) Multi-transcriptomic analysis and experimental validation implicate a central role of STAT3 in skin barrier Dysfunction Induced aggravation of Rosacea. J Inflamm Res 15:2141\u20132156","journal-title":"J Inflamm Res"},{"key":"3314_CR6","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.3389\/fimmu.2019.02847","volume":"10","author":"F Solimani","year":"2019","unstructured":"Solimani F, Meier K, Ghoreschi K (2019) Emerging topical and systemic JAK inhibitors in Dermatology. Front Immunol 10:2847","journal-title":"Front Immunol"},{"key":"3314_CR7","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nm1616","volume":"13","author":"K Yamasaki","year":"2007","unstructured":"Yamasaki K, Di Nardo A, Bardan A, Murakami M, Ohtake T, Coda A, Dorschner RA, Bonnart C, Descargues P, Hovnanian A, Morhenn VB, Gallo RL (2007) Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 13:975\u2013980","journal-title":"Nat Med"},{"key":"3314_CR8","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.intimp.2018.12.031","volume":"67","author":"Y Li","year":"2019","unstructured":"Li Y, Xie H, Deng Z, Wang B, Tang Y, Zhao Z, Yuan X, Zuo Z, Xu S, Zhang Y, Li J (2019) Tranexamic acid ameliorates rosacea symptoms through regulating immune response and angiogenesis. Int Immunopharmacol 67:326\u2013334","journal-title":"Int Immunopharmacol"},{"key":"3314_CR9","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1185\/030079907X199637","volume":"23","author":"JM Norquist","year":"2007","unstructured":"Norquist JM, Watson DJ, Yu Q, Paolini JF, McQuarrie K, Santanello NC (2007) Validation of a questionnaire to assess niacin-induced cutaneous flushing. Curr Med Res Opin 23:1549\u20131560","journal-title":"Curr Med Res Opin"},{"key":"3314_CR10","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.jaad.2014.05.044","volume":"71","author":"J Tan","year":"2014","unstructured":"Tan J, Liu H, Leyden JJ, Leoni MJ (2014) Reliability of Clinician Erythema Assessment grading scale. J Am Acad Dermatol 71:760\u2013763","journal-title":"J Am Acad Dermatol"},{"key":"3314_CR11","first-page":"841","volume":"14","author":"J Tan","year":"2015","unstructured":"Tan J, Leoni M (2015) Erythema of Rosacea: Validation of Patient\u2019s Self-Assessment Grading Scale. J Drugs Dermatol 14:841\u2013844","journal-title":"J Drugs Dermatol"},{"key":"3314_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.det.2017.11.001","volume":"36","author":"CS Ahn","year":"2018","unstructured":"Ahn CS, Huang WW (2018) Rosacea Pathogenesis. Dermatol Clin 36:81\u201386","journal-title":"Dermatol Clin"},{"key":"3314_CR13","first-page":"187","volume":"92","author":"LK Oge","year":"2015","unstructured":"Oge LK, Muncie HL, Phillips-Savoy AR (2015) Rosacea: diagnosis and treatment. Am Fam Physician 92:187\u2013196","journal-title":"Am Fam Physician"},{"key":"3314_CR14","first-page":"43","volume":"84","author":"R Odom","year":"2009","unstructured":"Odom R, Dahl M, Dover J, Draelos Z, Drake L, Macsai M, Powell F, Thiboutot D, Webster GF, Wilkin J, National Rosacea Society Expert Committee on the C, Staging of R (2009) Standard management options for rosacea, part 1: overview and broad spectrum of care. Cutis 84:43\u201347","journal-title":"Cutis"},{"key":"3314_CR15","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1001\/jama.2015.15287","volume":"314","author":"EJ van Zuuren","year":"2015","unstructured":"van Zuuren EJ, Fedorowicz Z (2015) Interventions for Rosacea. JAMA 314:2403\u20132404","journal-title":"JAMA"},{"key":"3314_CR16","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/jdv.19732","volume":"38","author":"RSQ Geng","year":"2024","unstructured":"Geng RSQ, Bourkas AN, Sibbald RG, Sibbald C (2024) Biomarkers in rosacea: a systematic review. J Eur Acad Dermatol Venereol 38:1048\u20131057","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3314_CR17","doi-asserted-by":"publisher","first-page":"674871","DOI":"10.3389\/fimmu.2021.674871","volume":"12","author":"Z Deng","year":"2021","unstructured":"Deng Z, Liu F, Chen M, Huang C, Xiao W, Gao S, Jian D, Ouyang Y, Xu S, Li J, Shi Q, Xie H, Zhang G, Li J (2021) Keratinocyte-Immune Cell Crosstalk in a STAT1-Mediated pathway: Novel insights into Rosacea Pathogenesis. Front Immunol 12:674871","journal-title":"Front Immunol"},{"key":"3314_CR18","doi-asserted-by":"crossref","unstructured":"Woo YR, Lim JH, Cho DH, Park HJ (2016) Rosacea: Molecular mechanisms and Management of a chronic cutaneous inflammatory Condition. Int J Mol Sci 17","DOI":"10.3390\/ijms17091562"},{"key":"3314_CR19","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1111\/cea.13217","volume":"48","author":"MAW Hermans","year":"2018","unstructured":"Hermans MAW, Schrijver B, van Holten-Neelen C, van Gerth R, van Hagen PM, van Daele PLA, Dik WA (2018) The JAK1\/JAK2- inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release. Clin Exp Allergy 48:1412\u20131420","journal-title":"Clin Exp Allergy"},{"key":"3314_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bbrc.2019.10.073","volume":"521","author":"T Liu","year":"2020","unstructured":"Liu T, Deng Z, Xie H, Chen M, Xu S, Peng Q, Sha K, Xiao W, Zhao Z, Li J (2020) ADAMDEC1 promotes skin inflammation in rosacea via modulating the polarization of M1 macrophages. Biochem Biophys Res Commun 521:64\u201371","journal-title":"Biochem Biophys Res Commun"},{"key":"3314_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ebiom.2018.02.009","volume":"30","author":"F Wang","year":"2018","unstructured":"Wang F, Zhang S, Jeon R, Vuckovic I, Jiang X, Lerman A, Folmes CD, Dzeja PD, Herrmann J (2018) Interferon Gamma induces reversible metabolic reprogramming of M1 macrophages to sustain cell viability and pro-inflammatory activity. EBioMedicine 30:303\u2013316","journal-title":"EBioMedicine"},{"key":"3314_CR22","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1002\/mc.23073","volume":"58","author":"N Blazanin","year":"2019","unstructured":"Blazanin N, Cheng T, Carbajal S, DiGiovanni J (2019) Activation of a protumorigenic IFNgamma\/STAT1\/IRF-1 signaling pathway in keratinocytes following exposure to solar ultraviolet light. Mol Carcinog 58:1656\u20131669","journal-title":"Mol Carcinog"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03314-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03314-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03314-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T16:09:00Z","timestamp":1729699740000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03314-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,24]]},"references-count":22,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["3314"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03314-4","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,24]]},"assertion":[{"value":"27 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments conformed to the institutional animal care guidelines and were approached by the Animal Ethics Review Committee of Shandong Second Medical University (Permit Number: 2023SDL315). All human subjects provided written informed consent. This study was approved by the Ethics Review Committee of Shandong Second Medical University and was conducted according to the principles of the Declaration of Helsinki (Permit Number: wyfy-2024-ky-135).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Patients signed informed consent regarding publishing their data and photographs.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"We declare no conflict of interest in the publication of this article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"566"}}